Cite
TXNIP is highly regulated in bone biopsies from patients with endogenous Cushing's syndrome and related to bone turnover.
MLA
Lekva, Tove, et al. “TXNIP Is Highly Regulated in Bone Biopsies from Patients with Endogenous Cushing’s Syndrome and Related to Bone Turnover.” European Journal of Endocrinology, vol. 166, no. 6, June 2012, pp. 1039–48. EBSCOhost, https://doi.org/10.1530/EJE-11-1082.
APA
Lekva, T., Ueland, T., Bøyum, H., Evang, J. A., Godang, K., & Bollerslev, J. (2012). TXNIP is highly regulated in bone biopsies from patients with endogenous Cushing’s syndrome and related to bone turnover. European Journal of Endocrinology, 166(6), 1039–1048. https://doi.org/10.1530/EJE-11-1082
Chicago
Lekva, Tove, Thor Ueland, Hege Bøyum, Johan Arild Evang, Kristin Godang, and Jens Bollerslev. 2012. “TXNIP Is Highly Regulated in Bone Biopsies from Patients with Endogenous Cushing’s Syndrome and Related to Bone Turnover.” European Journal of Endocrinology 166 (6): 1039–48. doi:10.1530/EJE-11-1082.